Victor Levitysky, Chief Scientific Officer of Targovax and primary insider, purchased on 2 December 2020 10,000 shares in Targovax ASA (“the Company”) at an average share price of NOK 10 per share. Following this transaction, Victor Levitsky holds 10,000 shares and 250,000 share options in the Company.
For further information, please contact:
Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Andreas Tinglum – Corporate Communications (Norway)
Phone: +47 9300 1773
Kim Sutton Golodetz – LHA Investor Relations (US)
Phone: +1 212-838-3777